Skip to main content
nanomedicines.org
Home
Publications
Login
You are here
Home
Biblio
Author
[
Keyword
]
Title
Type
Year
Filters:
Author
is
Bilsland, Alan
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Adenocarcinoma
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Animals
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Carcinoma, Squamous Cell
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Cell Line, Tumor
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Colorectal Neoplasms
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Female
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Genetic Therapy
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Genetic Vectors
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Humans
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Lac Operon
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Nanostructures
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Neoplasms
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Plasmids
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Polypropylenes
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Promoter Regions, Genetic
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Transfection
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Tumor Necrosis Factor-alpha
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Uterine Cervical Neoplasms
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar
Xenograft Model Antitumor Assays
Dufès C
,
W Keith N
,
Bilsland A
,
Proutski I
,
Uchegbu IF
,
Schätzlein AG
. 2005.
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
.
Cancer Res. 65(18):8079-84.
PubMed
Google Scholar